Aandeel 4576 D. WESTERN THERAPEUTICS INSTITUTE, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen D. Western Therapeutics Institute, Inc.

Aandelen

4576

JP3548740004

Vertraagde tijd Japan Exchange
Andere beurzen
 02:14:15 13-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
106 JPY +0,95% Intraday-grafiek van D. Western Therapeutics Institute, Inc. -1,85% -24,82%
14/02 D. Western Therapeutics Institute, Inc. Geeft geconsolideerde en niet-geconsolideerde winstrichtlijnen voor het volledige jaar eindigend op 31 december 2024 CI
2023 D. Western Therapeutics Institute, Inc. Geeft geconsolideerde winstrichtlijnen voor het volledige jaar eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
D. Western Therapeutics Institute, Inc. Provides Consolidated and Non Consolidated Earnings Guidance for the Full Year Ending December 31, 2024
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2023
D Western Therapeutics Institute : Summary of Consolidated Financial Results for the Six Months Ended June 30, 2023(Based on Japanese GAAP)
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2024
D. Western Therapeutics Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023
D Western Therapeutics Institute : FY12/22 Financial Results Briefing Materials
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022
D. Western Therapeutics Institute, Inc. announced that it has received ¥901.216203 million in funding from Whiz Partners Inc.
D. Western Therapeutics Institute, Inc. announced that it expects to receive ¥901.216203 million in funding from Whiz Partners Inc.
D. Western Therapeutics Institute, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2022
D Western Therapeutics Institute : Summary of Consolidated Financial Results for the Year Ended December 31, 2021(Based on Japanese GAAP)
D. Western Therapeutics Institute, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2022
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021
D. Western Therapeutics Institute, Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021
UBiENCE Inc. announced that it expects to receive ¥100 million in funding from D. Western Therapeutics Institute, Inc.
D. Western Therapeutics Institute, Inc. Reports Consolidated Financial Results for the First Quarter Ended March 31, 2021
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021
D. Western Therapeutics Institute, Inc. Reports Consolidated Financial Results for the Year Ended December 31, 2020
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 4576
  4. Nieuws D. Western Therapeutics Institute, Inc.
  5. Andere talen